About me
With a foundation of more than 20+ years in clinical trials, healthcare, and the pharmaceutical industry, Thad Wolfram brings a wealth of knowledge and experience to EmVenio. As President, he is focused on the growth of hybrid and decentralized trial capabilities and increased clinical trial diversity inclusion, improving the health and lives of patients. Before joining EmVenio, he was Executive Director, Corporate Strategy and Development at PPD, leading several initiatives focused on disruption and the future of clinical trials. Thad also held various senior leadership positions in consulting centered on science and research at EY and PA Consulting Group.
